,Topics,Questions
0,A statement that the study involves research,"Which of the following statements best reflects the nature of the activity described in the consent form?

A) The activity is a routine medical treatment not involving any research components.
B) The activity is a commercial product trial with the primary goal of marketing.
C) The activity is a research study aimed at investigating the effects of stellate ganglion block in patients with advanced Parkinson's disease.
D) The activity is a mandatory health screening program provided by the government.

Correct answer: C) The activity is a research study aimed at investigating the effects of stellate ganglion block in patients with advanced Parkinson's disease."
1,An explanation of the purposes of the research,"What is the primary goal of the ""Clinical study of stellate ganglion block in the treatment of patients with advanced Parkinson's disease"" research?
A) To assess the long-term effects of Parkinson's medication on cognitive function;
B) To evaluate the effectiveness of stellate ganglion block therapy in improving motor and non-motor symptoms in advanced Parkinson's disease patients;
C) To compare the cost-effectiveness of deep brain stimulation versus standard medication in Parkinson's treatment;
D) To investigate the genetic markers associated with Parkinson's disease progression.

Correct answer: B"
2,The expected duration of the subject's participation,"How long is the expected duration of participation for each subject in the ""Clinical study of stellate ganglion block in the treatment of patients with advanced Parkinson's disease""?
A) 6 weeks
B) 3 months
C) 1 year
D) 2 years

Correct answer: B) 3 months"
3,Any additional costs to the subject that may result from participation in the research,"Which of the following statements is true regarding any additional costs to the subject that may result from participation in the ""Clinical study of stellate ganglion block in the treatment of patients with advanced Parkinson's disease""?
A) The subject will bear the full cost of the stellate ganglion block treatment.
B) The cost of the stellate ganglion block treatment will be covered by the investigator, but routine medical expenses will be the responsibility of the patient.
C) All medical expenses, including routine and study-related costs, will be covered by the subject's insurance.
D) The subject will receive a stipend to cover all personal expenses during the study.

Correct answer: B) The cost of the stellate ganglion block treatment will be covered by the investigator, but routine medical expenses will be the responsibility of the patient."
4,A description of the procedures to be followed,"Which of the following procedures will be performed during the screening visit for the stellate ganglion block study in patients with advanced Parkinson's disease?

A) Assignment to the experimental or control group
B) Completion of a 10-meter walk test (10M-WT)
C) Administration of the stellate ganglion block therapy
D) Evaluation of the patient's response to the stellate ganglion block therapy

Correct answer: B) Completion of a 10-meter walk test (10M-WT)"
5,The consequences of a subject's decision to withdraw from the research and procedures for orderly termination of participation by the subject,"What will happen if you choose to withdraw from the clinical study at any time?
A) You will be required to reimburse the cost of the stellate ganglion block therapy; B) Your subsequent treatment may be adversely affected; C) You will be able to withdraw without any impact on your subsequent treatment; D) You will be obligated to continue participating in other unrelated studies.

Correct answer: C"
6,Identification of any procedures which are experimental,"Which of the following procedures is considered experimental in the context of this study on advanced Parkinson's disease?
A) Standard Parkinson's western medicine treatment
B) Routine clinical care including laboratory tests and imaging assessments
C) Stellate Ganglion Block (SGB) therapy in combination with standard treatment
D) Rehabilitation physiotherapy

Correct answer: C"
7,The approximate number of subjects involved in the study,"How many participants are expected to be enrolled in the ""Clinical study of stellate ganglion block in the treatment of patients with advanced Parkinson's disease""?
A) 20; B) 38; C) 45; D) 60

Correct answer: B"
8,A description of any reasonably foreseeable risks or discomforts to the subject,"Which of the following is a potential risk or discomfort associated with the stellate ganglion block procedure in the study for patients with advanced Parkinson's disease?
A) Temporary relief of Parkinson's symptoms; B) Allergic reactions to anesthetics; C) Improved cognitive function; D) Decreased hospital visits

Correct answer: B) Allergic reactions to anesthetics"
9,A description of any benefits to the subject or to others which may reasonably be expected from the research,"Which of the following is a potential benefit mentioned in the consent form for participants in the ""Clinical study of stellate ganglion block in the treatment of patients with advanced Parkinson's disease""?
A) Guaranteed cure for Parkinson's disease
B) Improvement in motor and non-motor symptoms as a result of the research treatment
C) Financial compensation for participation
D) A promise of personal health improvement

Correct answer: B"
10,"A disclosure of appropriate alternative procedures or courses of treatment, if any, that might be advantageous to the subject","What alternative treatments are available to subjects who choose not to participate in the stellate ganglion block study for advanced Parkinson's disease?
A) Subjects will be provided with a new experimental drug therapy not yet available to the public;
B) Subjects can receive standard Western medicine treatment and rehabilitation physiotherapy;
C) Subjects will be enrolled in a different clinical trial focusing on surgical interventions for Parkinson's disease;
D) There are no alternative treatments available outside of the study.

Correct answer: B"
11,"A statement describing the extent, if any, to which confidentiality of records identifying the subject will be maintained","Who is authorized to review your personal medical information for the purpose of ensuring the research is standardized and the data is true and reliable?

A) Only the principal investigator and the research team;
B) Government regulatory agencies and the ethics committee, in addition to your research doctor;
C) All hospital staff members;
D) Any third-party advertisers or pharmaceutical companies.

Correct answer: B) Government regulatory agencies and the ethics committee, in addition to your research doctor."
12,"For research involving more than minimal risk, an explanation as to whether any compensation, and an explanation as to whether any medical treatments are available, if injury occurs and, if so, what they consist of, or where further information may be obtained","What does the new consent form indicate about the treatment of research-induced injuries in the study of Stellate Ganglion Block in Patients With Advanced Primary Parkinsonâ€™s Disease?
A) The study will provide full compensation for any injuries caused by the research.
B) The study will immediately stop and necessary measures will be taken to ensure the safety of the subjects if a relevant adverse event occurs.
C) The study guarantees free lifelong medical treatment for any injuries resulting from participation.
D) The study offers health insurance coverage for any potential injuries during the research.

Correct answer: B) The study will immediately stop and necessary measures will be taken to ensure the safety of the subjects if a relevant adverse event occurs."
13,"Research, Rights or Injury: An explanation of whom to contact for answers to pertinent questions about the research and research subjects' rights, and whom to contact in the event of a research-related injury to the subject","If you experience an adverse event or injury during the study, whom should you immediately notify?
A) The principal investigator of the study; B) The local pharmacy; C) A family member; D) The Medical Ethics Committee of Zhujiang Hospital of Southern Medical University

Correct answer: A) The principal investigator of the study"
14,"A statement that participation is voluntary, refusal to participate will involve no penalty or loss of benefits to which the subject is otherwise entitled, and the subject may discontinue participation at any time without penalty or loss of benefits, to which the subject is otherwise entitled","What does the consent form state about your right to withdraw from the study?

A) Withdrawing from the study will result in a penalty.
B) You may withdraw from the study at any time without affecting your future medical care.
C) Refusal to participate will grant you additional benefits.
D) Withdrawing from the study requires you to pay a fee.

Correct answer: B) You may withdraw from the study at any time without affecting your future medical care."
